An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

NCT00185068 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Olmesartan medoxomil
DRUG: Olmesartan medoxomil/hydrochlorothiazide
DRUG: Hydrochlorothiazide

Sponsor

Daiichi Sankyo